Oslo - Delayed Quote NOK

Hofseth BioCare ASA (HBC.OL)

Compare
2.0200 -0.0300 (-1.46%)
At close: August 30 at 4:25 PM GMT+2
Loading Chart for HBC.OL
DELL
  • Previous Close 2.0500
  • Open 1.8500
  • Bid 1.0400 x 800000
  • Ask 2.0400 x 619400
  • Day's Range 1.8500 - 2.0400
  • 52 Week Range 1.8000 - 3.2600
  • Volume 47,785
  • Avg. Volume 61,202
  • Market Cap (intraday) 798.054M
  • Beta (5Y Monthly) 0.37
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 2000 and is headquartered in ?lesund, Norway.

www.hofsethbiocare.com

69

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HBC.OL

View More

Performance Overview: HBC.OL

Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HBC.OL
22.90%
OBX Total Return Index
12.84%

1-Year Return

HBC.OL
35.67%
OBX Total Return Index
16.72%

3-Year Return

HBC.OL
72.18%
OBX Total Return Index
31.06%

5-Year Return

HBC.OL
55.93%
OBX Total Return Index
72.11%

Compare To: HBC.OL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HBC.OL

View More

Valuation Measures

Annual
As of 8/30/2024
  • Market Cap

    798.05M

  • Enterprise Value

    942.21M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.67

  • Price/Book (mrq)

    5.77

  • Enterprise Value/Revenue

    4.25

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -52.67%

  • Return on Assets (ttm)

    -17.61%

  • Return on Equity (ttm)

    -95.34%

  • Revenue (ttm)

    230.08M

  • Net Income Avi to Common (ttm)

    -121.18M

  • Diluted EPS (ttm)

    -0.3000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    25.3M

  • Total Debt/Equity (mrq)

    129.06%

  • Levered Free Cash Flow (ttm)

    -140.4M

Research Analysis: HBC.OL

View More

Company Insights: HBC.OL

Research Reports: HBC.OL

View More

People Also Watch